COMPANY

SUS Clinicals Inc.

HQ: Cincinnati, OH source · susclinicals.com ↗ · Midwest

Location: Cincinnati, OH · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $400K (STTR Phase II 1R42CA302217-01A1, new, notice Aug 10, 2026). NIH RePORTER 1R42CA302217-01A1 (Aug 10, 2026)
Evidence (1 event)
- Aug 10, 2026 · NIH RePORTER 1R42CA302217-01A1
  Organization: SUS CLINICALS, INC.; City/State: CINCINNATI, OH; Project number: 1R42CA302217-01A1; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-08-10; FY total cost (award amount): 400001; Administering IC: National Cancer Institute; Project title: Development and Validation of Orthotopic Oncopig Glioma Models for Preclinical Locoregional Therapeutic Evaluation; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Aug 10, 2026 Grant Government grant — STTR: $400,001 (annual award, as published), announced Aug 10, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Apr 7, 2026 Partnership Partnership / licensing announced Apr 7, 2026. Source: company's own press page. source ↗
Dec 10, 2025 Partnership Partnership / licensing announced Dec 10, 2025. Source: company's own press page. source ↗

Last 2 years.

Apr 7, 2026 Partnership / licensing announced Apr 7, 2026. Source: company's own press page. source ↗
Dec 10, 2025 Partnership / licensing announced Dec 10, 2025. Source: company's own press page. source ↗
Aug 10, 2026 Government grant — STTR: $400,001 (annual award, as published), announced Aug 10, 2026. Agency: NIH/NCI. Source: government award database. source ↗

Annual award amounts. Total $2.0M.

Aug 7, 2024 NIH award 5R44CA285034-02 FY2024: $1,035,724 awarded for that fiscal year; activity R44 (SBIR); PI SCHACHTSCHNEIDER, KYLE; recipient as written: SUS CLINICALS, INC., CINCINNATI, OH. Validation of the Genetically Mall source ↗
Sep 19, 2023 NIH award 1R44CA285034-01 FY2023: $964,276 awarded for that fiscal year; activity R44 (SBIR); PI SCHACHTSCHNEIDER, KYLE; recipient as written: SUS CLINICALS, INC., CINCINNATI, OH. Validation of the Genetically Mallea source ↗